The Holistic prevention, management and treatment of Polycystic Ovarian Syndrome: The Common Antioxidants Flavonoids and Coenzyme Q10

By Kyle J. Norton Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                                         Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to  continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).



                        The prevention and management 

Polycystic ovary syndrome (PCOS) is unpreventable in Western medicine. Early diagnosis and treatment  may reduce risk of its complications, including infertility, metabolic syndrome, obesity, diabetes, cardiovascular diseases, stroke, etc.

Although PCOS cannot be completely avoided, strengthening immunity has shown a significant reduction of chronic inflammatory diseases(266)(267)(268).


                     The Common Antioxidants
3. Flavonoids
Flavonoids also known as Vitamin P and citrin are a yellow pigments having a structure similar to that of flavones occurred in varies plants. used in human history for over thousands of years for breakage of capillaries causes of swelling and obstruction of blood flow(553).
Flavonoids process a property as antioxidants for neutralization of many of reactive oxygen species (ROS)(554)(555), including singlet oxygen(556), hydroxyl(557) radicals involved chronic inflammatory diseases(558)(559).
Although nitric oxide is considered a free radical produced by immune system to destroy bacteria induced infection(561), over production can cause increased peroxynitrite which may attack protein, lipid and DNA(560). Flavonoids inhibit NO production of peroxynitrite through various antioxidant enzymes(562).

a. Quercetin
Quercetin is a plant-derived flavonoid found in fruits, vegetables, leaves and grains and studies show that quercetin may have anti-inflammatory(563)(564) and antioxidant(565)(566) properties as a antioxidant, quercetin scavenges free radicals(567), which damage cells (568) and cause mutation of cells with tampering DNA(569)(570).

b. Rutin
Rutin is a citrus flavonoid glycoside found in buckwheat and glycoside of the flavonoid quercetin. It inhibits platelet aggregation(571), decreases the capillary permeability(572), makes blood thinner and improves circulation. As an antioxidant, it also reduces the cytotoxicity of oxidized LDL cholesterol(573) triggered atherogenesis and the risks of other chronic inflammatory diseases(574)(575)(576).

c. Catechin
Catechin is a natural phenol antioxidant and natural anti-bacterial substance. Study showed catechin as good free radical scavenging power inhibits ROS production(577), may be be useful to the development of alimentary strategies to prevent ochratoxin A (OTA) cytotoxicity in human(578). As an antixidant, catchin also process anti inflammatory effects against many chronic inflammatory illness(579)(580)(581)(582).

d. Etc.

4. Coenzyme Q10
Coenzyme Q10 is discovered by Dr. Karl Folfers in 1957, serves as fuel for the cells(583) and acts an antioxidant to prevent the generation of free radicals during this process(584) induced numbers of chronic inflammatory diseases, such as diabetes(585)(586), cardiovascular(587)(588) and Parkinson's disease(589)(590). The antioxidanr also was  found effectivetively in the treatment of clomiphene-citrate-resistant PCOS patients through improving ovulation and clinical pregnancy rates when use combination with clomiphene citrate(591).

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months   
 
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O¹.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF¹, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R¹, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N¹, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB¹, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA¹, Arduc A², Tuna MM¹, Karakılıc E¹, Dagdelen I¹, Tutuncu Y¹, Berker D¹, Guler S¹.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO¹.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO¹, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J¹, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK¹, Katalenich B², Nagireddy P³, Chabbra P⁴, Kuhadiya N⁵, Fonseca V¹.(PubMed)
(14) Acne in hirsute women by Lumezi BG¹, Pupovci HL¹, Berisha VL¹, Goçi AU², Gerqari A³.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. by Whigham LD¹, Butz DE², Dashti H³, Tonelli M³, Johnson LK¹, Cook ME², Porter WP⁴, Eghbalnia HR⁵, Markley JL⁶, Lindheim SR⁷, Schoeller DA⁸, Abbott DH⁹, Assadi-Porter FM¹⁰.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA¹, Azizia MM¹, Hardiman PJ².(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M¹, Kjaer SK², Jensen A¹, Munk C¹, Mellemkjaer L³.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E¹.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E¹, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(266) [Immunopathological responses in women with chronic inflammatory diseases of the uterus and appendages and their therapeutic correction].[Article in Russian] by Medvedev BI¹, Kazachkova EA, Kazachkov EL.(PubMed)
(267) Cross Talk Between ER Stress, Oxidative Stress, and Inflammation in Health and Disease by Dandekar A¹, Mendez R, Zhang K.(PubMed)
(268) New dog and new tricks: evolving roles for IL-33 in type 2 immunity by Lott JM¹, Sumpter TL¹, Turnquist HR².(PubMed)
(553) THE HIERARCHY OF FLAVONOID ANTIOXIDANT POTENTIALS/2003 Nita Bishop, N.D. Presented ! at AANP (American ! Association of ! Naturopathic Physicians) Convention 2003 ! in Portland, ! Oregon
(554) Apoptosis Induction by the Total Flavonoids from Arachniodes exilis in HepG2 Cells through Reactive Oxygen Species-Mediated Mitochondrial Dysfunction Involving MAPK Activation by Li H¹, Chen J², Xiong C², Wei H², Yin C³, Ruan J².(PubMed)
(555) Tissue injury by reactive oxygen species and the protective effects of flavonoids by de Groot H¹, Rauen U.(PubMed)
(556) Antioxidant activity of flavonoids: efficiency of singlet oxygen (1 delta g) quenching by Tournaire C¹, Croux S, Maurette MT, Beck I, Hocquaux M, Braun AM, Oliveros E.(PubMed)
(557) Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation by Ozyürek M¹, Bektaşoğlu B, Güçlü K, Apak R.(PubMed)
(558) Phytochemicals and their potential usefulness in inflammatory bowel disease by Somani SJ¹, Modi KP, Majumdar AS, Sadarani BN.(PubMed)
(559) Kolaviron, a biflavonoid complex of Garcinia kola seeds modulates apoptosis by suppressing oxidative stress and inflammation in diabetes-induced nephrotoxic rats by Ayepola OR¹, Cerf ME², Brooks NL³, Oguntibeju OO⁴.(PubMed)
(560) Nitric oxide and peroxynitrite in health and disease by Pacher P¹, Beckman JS, Liaudet L.(PubMed)
(561) The effects of nitric oxide on the immune system during Trypanosoma cruzi infection by Gutierrez FR¹, Mineo TW, Pavanelli WR, Guedes PM, Silva JS.(PubMed)
(562) Flavonoids in prevention of diseases with respect to modulation of Ca-pump function by Lubica Horáková(PubMed)
(563) Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages by Hämäläinen M¹, Nieminen R, Vuorela P, Heinonen M, Moilanen E.(PubMed)
(564) The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells by García-Mediavilla V¹, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, Tuñón MJ, González-Gallego J.(PubMed)
(565) Plasma metabolites of quercetin and their antioxidant properties by Morand C¹, Crespy V, Manach C, Besson C, Demigné C, Rémésy C.(PubMed)
(566) Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin by Dueñas M¹, González-Manzano S, González-Paramás A, Santos-Buelga C.(PubMed)
(567) Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study by Huk I¹, Brovkovych V, Nanobash Vili J, Weigel G, Neumayer C, Partyka L, Patton S, Malinski T.(PubMed)
(568) Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats by Ghosh A¹, Sarkar S, Mandal AK, Das N.(PubMed)
(569) Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo by Oršolić N¹, Car N.(PubMed)
(570) The effect of quercetin on oxidative DNA damage and myelosuppression induced by etoposide in bone marrow cells of rats by Papież MA¹.(PubMed)
(571) Effect of Scutia buxifolia Reissek in nucleotidase activities and inhibition of platelet aggregation by Boligon AA¹, Pimentel VC, Bagatini MD, Athayde ML.(PubMed)
(572) [Effect of rutin (rutinion) on capillary permeability].[Article in Undetermined Language] by BLAICH W, TUSHAUS B.(PubMed)
(573) Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids by Jeong YJ¹, Choi YJ, Kwon HM, Kang SW, Park HS, Lee M, Kang YH.(PubMed)
(574) The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy by Azevedo MI, Pereira AF, Nogueira RB, Rolim FE, Brito GA, Wong DV, Lima-Júnior RC, de Albuquerque Ribeiro R, Vale ML¹.(PubMed)
(575) Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion by Qu J¹, Zhou Q, Du Y, Zhang W, Bai M, Zhang Z, Xi Y, Li Z, Miao J.(PubMed)
(576) Anti-inflammatory and antioxidative effects of the methanolic extract of the aerial parts of Mitracarpus frigidus in established animal models by Fabri RL¹, Garcia RA, Florêncio JR, de Castro Campos Pinto N, de Oliveira LG, Aguiar JA, Ribeiro A, Scio E.(PubMed)
(577) Synergistic antioxidant effect of catechin and malvidin 3-glucoside on free radical-initiated peroxidation of linoleic acid in micelles by Rossetto M¹, Vanzani P, Mattivi F, Lunelli M, Scarpa M, Rigo A.(PubMed)
(578) Protective role of oligonol from oxidative stress-induced inflammation in C6 glial cell by Ahn JH¹, Choi JW¹, Choi JM¹, Maeda T², Fujii H², Yokozawa T³, Cho EJ¹.(PubMed)
(579) Catechins: natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1) by Costa S¹, Utan A, Cervellati R, Speroni E, Guerra MC.(PubMed)
(580) Periodontal pathogens and atherosclerosis: implications of inflammation and oxidative modification of LDL by Kurita-Ochiai T¹, Yamamoto M¹.(PubMed)
(581) UP446, analgesic and anti-inflammatory botanical composition by Yimam M¹, Brownell L, Pantier M, Jia Q.(PubMed)
(582) In vitro anti-inflammatory activity of phenolic rich extracts from white and red common beans by García-Lafuente A¹, Moro C², Manchón N², Gonzalo-Ruiz A³, Villares A², Guillamón E², Rostagno M², Mateo-Vivaracho L².(PubMed)
(583) A combination of lipoic acid plus coenzyme Q10 induces PGC1α, a master switch of energy metabolism, improves stress response, and increases cellular glutathione levels in cultured C2C12 skeletal muscle cells by Wagner AE¹, Ernst IM, Birringer M, Sancak O, Barella L, Rimbach G.(PubMed)
(584) Coenzyme q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxdiation in chronic gastritis associated with H. pylori infection by Rahmani A¹, Abangah G, Moradkhani A, Hafezi Ahmadi MR, Asadollahi K.(PubMed)
(585) Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes by Hodgson JM¹, Watts GF, Playford DA, Burke V, Croft KD.(PubMed)
(586) The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study by Mezawa M¹, Takemoto M, Onishi S, Ishibashi R, Ishikawa T, Yamaga M, Fujimoto M, Okabe E, He P, Kobayashi K, Yokote K.(PubMed)
(587) Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness by Maes M¹, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.(PubMed)
(588) Coenzyme Q10 in cardiovascular disease by Pepe S¹, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL.(PubMed)
(589) Coenzyme Q10 for Parkinson's disease by Liu J¹, Wang L, Zhan SY, Xia Y.(PubMed)
(590) The Effect of Creatine and Coenzyme Q10 Combination Therapy on Mild Cognitive Impairment in Parkinson's Disease by Li Z¹, Wang P, Yu Z, Cong Y, Sun H, Zhang J, Zhang J, Sun C, Zhang Y, Ju X.(PubMed)
(591) Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome by El Refaeey A¹, Selem A², Badawy A³.(PubMed)